Logo image of WHN.CA

WESTHAVEN GOLD CORP (WHN.CA) Stock Fundamental Analysis

TSX-V:WHN - CA9603501060 - Common Stock

0.16 CAD
+0.01 (+6.67%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

1

WHN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 803 industry peers in the Metals & Mining industry. The financial health of WHN is average, but there are quite some concerns on its profitability. WHN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year WHN has reported negative net income.
WHN had a negative operating cash flow in the past year.
In the past 5 years WHN always reported negative net income.
WHN had a negative operating cash flow in each of the past 5 years.
WHN.CA Yearly Net Income VS EBIT VS OCF VS FCFWHN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

WHN's Return On Assets of -4.65% is fine compared to the rest of the industry. WHN outperforms 71.98% of its industry peers.
Looking at the Return On Equity, with a value of -5.00%, WHN is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
Industry RankSector Rank
ROA -4.65%
ROE -5%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WHN.CA Yearly ROA, ROE, ROICWHN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

WHN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WHN.CA Yearly Profit, Operating, Gross MarginsWHN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

WHN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WHN.CA Yearly Shares OutstandingWHN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
WHN.CA Yearly Total Debt VS Total AssetsWHN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

WHN has an Altman-Z score of 6.90. This indicates that WHN is financially healthy and has little risk of bankruptcy at the moment.
WHN has a better Altman-Z score (6.90) than 65.88% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that WHN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, WHN is in line with its industry, outperforming 55.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.9
ROIC/WACCN/A
WACCN/A
WHN.CA Yearly LT Debt VS Equity VS FCFWHN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.23 indicates that WHN should not have too much problems paying its short term obligations.
WHN has a Current ratio (1.23) which is comparable to the rest of the industry.
A Quick Ratio of 1.23 indicates that WHN should not have too much problems paying its short term obligations.
WHN has a Quick ratio of 1.23. This is comparable to the rest of the industry: WHN outperforms 48.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
WHN.CA Yearly Current Assets VS Current LiabilitesWHN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.23% over the past year.
EPS 1Y (TTM)53.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WHN.CA Yearly EPS VS EstimatesWHN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0 -0.01 -0.01 -0.02

0

4. Valuation

4.1 Price/Earnings Ratio

WHN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WHN.CA Price Earnings VS Forward Price EarningsWHN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WHN.CA Per share dataWHN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

WHN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WESTHAVEN GOLD CORP

TSX-V:WHN (9/3/2025, 7:00:00 PM)

0.16

+0.01 (+6.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-26 2025-11-26
Inst Owners4.32%
Inst Owner ChangeN/A
Ins Owners14.41%
Ins Owner ChangeN/A
Market Cap33.46M
Analysts84.44
Price Target1.17 (631.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.17%
PT rev (3m)-4.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.65%
ROE -5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11675.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 6.9
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)33914.5%
Cap/Depr(5y)56519.6%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.01%
OCF growth 3YN/A
OCF growth 5YN/A